Sage Therapeutics (NASDAQ:SAGE) Downgraded by StockNews.com to “Sell”
Sage Therapeutics (NASDAQ:SAGE – Get Free Report) was downgraded by equities research analysts at StockNews.com from a “hold” rating to a “sell” rating in a research report issued to clients and investors on Monday. Several other equities research analysts also recently weighed in on SAGE. Wedbush restated a “neutral” rating and issued a $6.00 target […]
Sage Therapeutics (NASDAQ:SAGE – Get Free Report) was downgraded by equities research analysts at StockNews.com from a “hold” rating to a “sell” rating in a research report issued to clients and investors on Monday. Several other equities research analysts also recently weighed in on SAGE. Wedbush restated a “neutral” rating and issued a $6.00 target […]
